Evidence map›Paper›PMID 40783654›Full record

ReviewEuropean radiology2026

Balancing patients' benefits and risks in computed tomography: a European Society of Radiology 'EuroSafe Imaging' viewpoint.

John Damilakis, Claudio Granata, Elmar Kotter, Boris Brkljacic, European Society of Radiology (ESR)

Abstract readReview
In one paragraph

Review in European radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

John DamilakisDepartment of Medical Physics, School of Medicine, University of Crete, Crete, Greece. john.damilakis@med.uoc.gr.ORCID http://orcid.org/0009-0001-1650-8955
Claudio GranataDepartment of Paediatric Radiology, Institute for Maternal and Child Health, IRCCS "Burlo Garofolo", Trieste, Italy.
Elmar KotterDepartment of Diagnostic and Interventional Radiology, Medical Center University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Boris BrkljacicUniversity Hospital Dubrava, University of Zagreb School of Medicine, Zagreb, Croatia.
European Society of Radiology (ESR)

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Every physician seeks to do more good than harm. A surgeon operates with the expectation that the benefits of the operation outweigh the risks associated with the surgery, leaving the patient in a better condition than before the procedure. Radiologists provide enormous benefits for patients-identifying diseases that could not otherwise be diagnosed or staging disease severity to allow for the most appropriate treatments to be undertaken. However, like any intervention, radiological studies are associated with risks; ionizing radiation may not be as apparent as a surgical site infection to patients or even other healthcare providers, but it carries inherent and cumulative risk and portends real hazard for patients. This article explores the responsibility of radiologists to champion appropriate imaging selection through rigorous justification of studies and protocol optimization when imaging is indicated. KEY POINTS: Irradiating patients for CT imaging provides tremendous diagnostic value, but is associated with an increased risk of cancer. The risk of CT-associated malignancies should be discussed with patients in an understandable way, considering individual- and population-level hazard. Strict application of the ALARA principle allows for maximizing benefits from imaging studies while minimizing harm.

Indexed as

Neoplasms, Radiation-InducedRadiologyTomography, X-Ray ComputedEuropeHumansRadiation DosageRisk AssessmentSocieties, MedicalCancerCTEurosafe

Identifiers

PMID40783654
PMCPMC12953355

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.